Metastatic Colorectal Cancer: Personalized Treatment Study

We are investigating whether tailored therapies based on genetic testing can improve treatment outcomes for patients with metastatic colorectal cancer. This study aims to assess the effectiveness and safety of these new treatment options.

Efficacy phase (II)No Placebo Investigational Medicines Oral InjectionGastroenterologyOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Afinitor

Afinitor is a cancer medicine used to treat certain types of tumors and abnormal growths, including some kidney, breast, and brain tumors.

Alecensa

Alecensa is a cancer medicine used to treat certain types of lung cancer caused by specific genetic changes.

Farydak

Farydak is a medicine used to treat multiple myeloma, a type of blood cancer.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Alectinib Hydrochloride

Alectinib hydrochloride is a substance that targets lung cancers with an ALK gene change to slow tumor growth and spread.

Binimetinib

Binimetinib is a targeted cancer treatment that blocks a protein pathway to slow growth of certain tumors, including some melanomas.

Crizotinib

Crizotinib is a substance that blocks specific cancer cell signals to treat certain types of lung cancer with particular genetic changes.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Perjeta

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Aderolio

Aderolio 250 Mcg Tablets

Aderolio 500 Mcg Tablets

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Oslo University Hospital HF

Department for clinical research

Oslo, Norway

Sponsor: Oslo University Hospital HF

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.